Analyst Reco. MAIA Biotechnology, Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:00 18/06/2024 BST			5-day change	1st Jan Change
3.54 ^USD	-6.35%		-4.84%	+202.56%

06-07	MAIA Biotechnology Shares Rise After FDA's Telomerase Inhibitor Approval Shows Viability of Such Therapies	DJ
06-07	MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA?s Approval of a Telomerase Inhibitor Agent Therapy	CI

Maia Biotechnology Insider Bought Shares Worth $299,409, According to a Recent SEC Filing	04-26	MT
Noble Capital Starts MAIA Biotechnology at Outperform With $14 Price Target	21/02/23	MT

No results for this search